CONCORD.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
CONCORD.BOConcord Drugs Limited	$78.00	-0.71%	$866M	—
ASPIRA.BOAspira Pathlab & Diagnostics Limited	$99.75	+0.00%	$1.0B	—
BIOFILCHEM.BOBiofil Chemicals and Pharmaceuticals Limited	$33.85	+0.33%	$552M	—
CHOKSI.BOChoksi Asia Limited	$219.20	-0.79%	$1.2B	—
GODAVARI.BOGodavari Drugs Limited	$112.00	+2.85%	$1.1B	—
MAKERSL.BOMakers Laboratories Limited	$180.95	+5.76%	$1.1B	—
RAJNISH.BORajnish Wellness Limited	$0.39	+2.63%	$396M	—

Source: Financial Modeling Prep · peers by sector/industry

Concord Drugs Limited

Established on April 24, 1995, Concord Drugs Limited is a pharmaceutical firm based in Hyderabad, India, dedicated to manufacturing and distributing a broad spectrum of medicinal formulations. Its extensive product line encompasses ready-to-fill pellets, specialized MUP's tissue bio-adhesives, injectable drugs, a variety of oral solid dosages, and liquid oral preparations.

www.concorddrugs.in

Employees: 185
IPO / List date: Feb 23, 2015
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds CONCORD.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in CONCORD.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded CONCORD.BO yet.